1. Academic Validation
  2. Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy in vitro

Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy in vitro

  • Nanomedicine (Lond). 2017 Apr;12(7):711-728. doi: 10.2217/nnm-2016-0388.
Cinzia Ingallina 1 2 Pedro M Costa 1 Francesca Ghirga 3 Rebecca Klippstein 1 Julie T Wang 1 Simone Berardozzi 2 3 Naomi Hodgins 1 Paola Infante 3 Steven M Pollard 4 Bruno Botta 2 Khuloud T Al-Jamal 1
Affiliations

Affiliations

  • 1 Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King's College London, Franklin-Wilkins Building, London, SE1 9NH, UK.
  • 2 Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Rome, Italy.
  • 3 Center for Life NanoScience@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy.
  • 4 MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh bioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UK.
Abstract

Aim: With the purpose of delivering high doses of glabrescione B (GlaB) to solid tumors after systemic administration, long-circulating GlaB-loaded oil-cored polymeric nanocapsules (NC-GlaB) were formulated.

Materials & methods: Synthesis of GlaB and its encapsulation in nanocapsules (NCs) was performed. Empty and GlaB-loaded NCs were assessed for their physico-chemical properties, in vitro cytotoxicity and in vivo biodistribution.

Results: GlaB was efficiently loaded into NCs (∽90%), which were small (∽160 nm), homogeneous and stable upon storage. Further, GlaB and NC-GlaB demonstrated specific activities against the Cancer Stem Cells. Preliminary studies in tumor-bearing mice supported the ability of NC to accumulate in pancreatic tumors.

Conclusion: This study provides early evidence that NC-GlaB has the potential to be utilized in a preclinical setting and justifies the need to perform therapeutic experiments in mice.

Keywords

Hedgehog (Hh) pathway; glabrescione B (GlaB); oil-cored polymeric nanocapsules.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-122590
    98.05%, Gli1-DNA Interaction Inhibitor
    Gli